Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.03
-0.19 (-3.05%)
At close: Jun 16, 2026, 4:00 PM EDT
6.15
+0.12 (1.99%)
After-hours: Jun 16, 2026, 5:56 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $393.2 million as of June 16, 2026. Its market cap has increased by 179.22% in one year.
Market Cap
393.20M
Enterprise Value
284.70M
1-Year Change
179.22%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $393.20M, an increase of 538.11%. That is a compound annual growth rate of 42.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 393.20M | 3.14% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 412.80M |
| Ocugen | 409.61M |
| vTv Therapeutics | 406.60M |
| Century Therapeutics | 405.80M |
| Indaptus Therapeutics | 405.41M |
| Monopar Therapeutics | 400.39M |
| Sagimet Biosciences | 400.15M |
| Benitec Biopharma | 384.08M |